U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced a new federal initiative to build a comprehensive autism data platform using Medicare and Medicaid records. Designed to study the causes of autism spectrum disorder (ASD), the platform will integrate claims data, electronic health records, and data from wearable health devices, according to the Department of Health and Human Services (HHS).
The National Institutes of Health (NIH) and the Centers for Medicare and Medicaid Services (CMS) will collaborate on the effort, which is part of a broader $50 million research initiative to investigate potential environmental and medical causes of autism. Kennedy stated the project aims to provide "honest answers families have waited far too long to hear," despite his controversial history promoting a debunked link between vaccines and autism.
HHS said the platform will help researchers analyze autism diagnoses, treatment outcomes, healthcare access disparities, and the financial impact on families. However, experts like Dr. Helen Tager-Flusberg of Boston University argue the focus does not directly address autism’s root causes. She also noted that an existing NIH autism database recently went offline without explanation, raising concerns about transparency.
The project has sparked privacy questions, as HHS has not confirmed whether the database will be anonymous or voluntary. Autism researcher Eric Rubenstein noted that Medicaid and Medicare data offer insights into health disparities but lack environmental exposure data, which Kennedy claims he will explore.
Autism rates have surged in recent years, with the CDC reporting 1 in 31 U.S. 8-year-olds diagnosed in 2022. While Kennedy aims to identify autism’s causes by September, scientists emphasize that autism likely stems from a complex mix of genetic and environmental factors. Critics warn against oversimplifying this ongoing scientific challenge.


U.S. Flags Vietnam as “Priority Foreign Country” Over Intellectual Property Concerns
Vanda Pharmaceuticals (VNDA) Stock Soars After FDA Approves BYSANTI for Bipolar I and Schizophrenia
RFK Jr. Expands CDC Vaccine Advisory Panel's Scope Amid Legal Battles
US Sanctions Target Iran’s Shadow Banking Network and Terror Financing
Trump Expands Cuba Sanctions Targeting Key Sectors and Foreign Entities
FEMA Reinstates Employees After Dissent Letter, Signaling Shift in Workforce Stability
Hantavirus Cruise Ship Outbreak Triggers Global Health Alert
Medicare to Cover GLP-1 Weight-Loss and Diabetes Drugs Starting July 1
Novo Nordisk Shares Tumble After CagriSema Misses Key Trial Endpoint
New York Moves to Ban Masked Law Enforcement During Immigration Operations
Australia Targets Meta, Google, and TikTok With New News Payment Tax Proposal
CDC Monitors U.S. Travelers After Hantavirus Outbreak on Luxury Cruise Ship
Judge Rules Use of Military Lawyers in Civilian Prosecutions Is Lawful
Rubio Approves $25.8 Billion Weapons Sale to Middle East Allies
White House Withdraws Trump’s National Park Service Nominee Amid Criticism
U.S. Sanctions Former DR Congo President Joseph Kabila Over Rebel Support 



